Status:
COMPLETED
Subthalamic Nucleus (STN) Stimulation and Obsessive-Compulsive Disorder (OCD)
Lead Sponsor:
Marie-laure Welter
Collaborating Sponsors:
Assistance Publique - Hôpitaux de Paris
Conditions:
Obsessive Compulsive Disorder
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
PHASE2
Brief Summary
Obsessive-compulsive disorder is a disabling and frequent disorder. In some patients, the medical treatment is ineffective. The pathophysiology of this disease is still unknown. Some data suggest that...
Eligibility Criteria
Inclusion
- Severe obsessive-compulsive disorder
Exclusion
- Contraindication to magnetic resonance imaging (MRI)
- Severe cognitive or behavioral disorders
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00169377
Start Date
October 1 2005
End Date
May 1 2007
Last Update
March 22 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Bordeaux, France
2
Clermont-Ferrand, France
3
Grenoble, France
4
Nantes, France